跳至主要内容
临床试验/EUCTR2011-006084-22-GB
EUCTR2011-006084-22-GB进行中(未招募)不适用

tilising drug levels and anti-drug antibodies to predict response to treatment in patients with Inflammatory Bowel Disease - Trough levels of anti-TNF agents in inflammatory bowel disease

Royal Liverpool University Hospital0 个研究点目标入组 0 人开始时间: 2012年8月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Patients with an established diagnosis of IBD (Crohn's disease or ulcerative colitis) who are already on treatment or being initiated on treatment with anti-TNF agents
  • 2. Patients who experience an adverse event with infliximab or adalimumab
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 190
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • 1. Inability to consent to the study
  • 2. Patients with IBD who are not on anti-TNF therapy

研究者

相似试验